Default: Therapeutic Advances in Respiratory Disease

ISSN: 1753-4658

Journal Home

Journal Guideline

Therapeutic Advances in Respiratory Disease Q1 Unclaimed

SAGE Publications Ltd United Kingdom
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Therapeutic Advances in Respiratory Disease is a journal indexed in SJR in Pulmonary and Respiratory Medicine and Pharmacology (medical) with an H index of 46. It is an CC BY-NC Journal with a Single blind Peer Review review system, and It has a price of 1800 €. The scope of the journal is focused on respiratory diseases, respiratory disorders, respiratory medicine. It has an SJR impact factor of 1,092 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,092.

Type: Journal

Type of Copyright: CC BY-NC

Languages: English

Open Access Policy: Open Access

Type of publications:

Publication frecuency: -

Price

1800 €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

Therapeutic Advances in Respiratory Disease

1,092

SJR Impact factor

46

H Index

66

Total Docs (Last Year)

200

Total Docs (3 years)

3170

Total Refs

793

Total Cites (3 years)

189

Citable Docs (3 years)

4.11

Cites/Doc (2 years)

48.03

Ref/Doc

Comments

No comments ... Be the first to comment!

Aims and Scope


Respiratory diseases Respiratory disorders Respiratory medicine



Best articles by citations

The IDDEA project: a strategy for the detection of alpha-1 antitrypsin deficiency in COPD patients in the primary care setting

View more

Respiratory failure, lung infiltrates, and hemoptysis in a woman with chronic isopropyl alcohol inhalation

View more

Modifiable risk factors associated with bronchiolitis

View more

Review: Safety of long-acting beta2 -agonists in the treatment of asthma

View more

Pulmonary artery diastolic pressure gradient as an indicator of severity of illness in patients with pulmonary hypertension related to left-sided heart disease

View more

Polymorphisms of the beta2 adrenoreceptor gene in chronic obstructive pulmonary disease

View more

Intrapleural hemorrhage after administration of tPA: a case report and review of the literature

View more

Are nicotine replacement therapy, varenicline or bupropion options for pregnant mothers to quit smoking? Effects on the respiratory system of the offspring

View more

Clinical assessment of the obstructive sleep apnoea/hypopnoea syndrome

View more

Alpha-1-antitrypsin deficiency: increasing awareness and improving diagnosis

View more

Characterisation of exacerbations of chronic bronchitis and COPD in Europe: the GIANT study

View more

A new horizon in the treatment of biofilm-associated tonsillitis

View more
SHOW MORE ARTICLES

MIRU-VNTR typing of drug-resistant tuberculosis isolates in Greece

View more

The impact of psychological distress on exacerbation rates in COPD

View more

New treatment options for bronchiectasis

View more

Review: Systemic consequences of COPD

View more

The benefits of long-term systemic antimicrobial therapy in chronic obstructive pulmonary disease

View more

Diagnostic yield and safety of sputum induction with nebulized racemic salbutamol versus hypertonic saline in smear-negative pulmonary tuberculosis

View more

Patient and provider perceptions of sleep disordered breathing assessment during prenatal care: a survey-based observational study

View more

Clinicopharmacological profile of the fixed-dose combination of aclidinium bromide and formoterol fumarate in the management of chronic obstructive pulmonary disease

View more

Antifungal medication is efficient in the treatment of sarcoidosis

View more

Matrix metalloprotease polymorphisms are associated with gas transfer in alpha 1 antitrypsin deficiency

View more

Pharmacotherapy of asthma: regular treatment or on demand?

View more

Storage in ultra-low-temperature decreases the levels of IgM anticardiolipin antibody in serum samples from tuberculosis patients

View more

FAQS